ARCHIVES

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

This article is from The Cancer Letter archive.

Vol. 08 No. 13 | March 26, 1982

Download PDF Visit The Full Archive

Related Articles

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

Centers Ask Americans for $1 Each for Research.

May 16, 2008

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

March 26, 1993

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985